Intravenous iron for anemia after gastric cancer surgery
Treatments studied
Part of Blood & lymphatic, Cancer, Digestive system, Hormones & metabolism clinical trials.
This trial compares two types of IV iron treatments to see which one works better for people who have anemia after gastric cancer surgery. If you're eligible, you could get either ferric carboxymaltose or iron sucrose to help boost your iron levels and improve your anemia.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 75 years old and weigh at least 50 kg (~110 lbs).
- You must have been diagnosed with gastric cancer (stage I–III) and had surgery to remove it.
- You must have become anemic right after surgery, with hemoglobin below 10 g/dL on the first day.
- You must have iron deficiency, confirmed by blood tests.
- You must not have taken iron supplements (oral or IV) or erythropoietin (EPO) within the past 3 months.
- You must be generally healthy enough for the trial, with no severe liver, kidney, or bleeding issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether giving an iron infusion before surgery can improve outcomes for people with gastric cancer who are going to have their stomach removed. The goal is to see if it helps with recovery or reduces complications.
This trial tests whether adding an iron supplement to a combination of chemotherapy and immunotherapy before surgery can improve outcomes for patients with locally advanced gastric cancer. It aims to see if this approach is safe and effective.
This Phase 3 study tests whether giving a specific iron medicine before major gynecologic cancer surgery can improve recovery. It’s mainly for people with low blood counts from low iron stores before surgery.
This Phase 3 study tests whether giving ferric carboxymaltose (an IV iron treatment) helps people with advanced stomach or stomach–esophagus cancer and iron-deficiency anemia. The goal is to improve safety and how well the standard first-line cancer treatment works.
This trial tests whether giving iron directly into the bloodstream before surgery improves recovery for people with colorectal cancer who have low iron but are not anemic. It may help reduce fatigue and the need for blood transfusions after surgery.
This Phase 3 study tests whether giving iron (as ferric carboxymaltose) after complex major surgery can improve recovery by helping your body rebuild blood and oxygen levels after blood loss. It may help patients who are having certain types of aortic, liver, or pancreas operations.
Hear when a new Gastric Cancer (GC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.